Bengaluru-based health tech start-up SigTuple Technologies has raised $4.3 million (around Rs 34 crore) in its Series C funding round led by Endiya Ventures and Accel. Additionally, multiple other health tech investors also joined the round.
With the help of this newly generated fund, the company aims to expand its footprint, across multiple geographies. Additionally, it wants to diversify its product portfolio.
Since its inception in 2015, the company has raised $45 million (Rs 192 crore) till now. It raised $19 million in 2019 as a mixture of equity and debt funding. The round was led by Trusted Insight and Accel, Chiratae Ventures, Pi Ventures, Binny Bansal (co-founder of Flipkart) and Trifecta Capital.
The SigTuple group consists of three companies, SigTuple Technologies, Mirable Health Services and Truelyser BioSystems.
Commenting on the latest development, Tathagato Rai Dastidar, founder and chief executive officer (CEO), said, “2023 is the year SigTuple will expand across key markets in Southeast Asia, Middle East and North Africa, North America and Europe. “
Addressing the investment, Ramesh Byrapaneni, managing director, Endiya Partners, said, “SigTuple is combining digitization and AI technology for peripheral blood smears and urine samples, the two most common tests in pathology labs worldwide. SigTuple is also expanding its AI solutions to hematology, cytology, and microbiology.”
According to a report by VCCircle, the health tech sector in India is getting attraction from investors. Last Year, health tech firm BeatO raised $33 million in its Series B funding round. Gurugram-headquartered start-up Breath Well Being also raised Rs 50 crore ($6 million) in its Series B round in January, this year.